Tracking Renaissance Technologies (RenTec) 13F Portfolio - Q4 2025 Update
Source: SeekingAlpha
2026-02-20 11:04:14 ET
This article is part of a series that provides an ongoing analysis of the changes made to Renaissance Technologies US stock portfolio on a quarterly basis. It is based on their 13F Form filed on 02/12/2026. Please check out our last article for the changes made during Q3 2025....
Read the full article on Seeking Alpha
For further details see:
Tracking Renaissance Technologies (RenTec) 13F Portfolio - Q4 2025 Update
Exelixis Inc.
NASDAQ: EXEL
EXEL Trading
0.08% G/L:
$41.70 Last:
841,852 Volume:
$42.50 Open:
EXEL Latest News
February 28, 2026 04:57:00 am
3 Reasons Exelixis Stock Could Deliver Market?Beating Returns Over the Next Decade
February 24, 2026 04:05:00 pm
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
February 24, 2026 10:58:00 am
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
February 20, 2026 04:05:00 pm
Exelixis: The Cash?Generating Biotech That I Think Deserves a Closer Look in 2026
EXEL Stock Data
$11,614,618,641
260,551,394
1.54%
313
N/A
Biotechnology & Life Sciences
Healthcare
US
Alameda
